News
Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 8:00 AM ETCompany ParticipantsAlbert Bourla - Chairman of ...
3h
Zacks Investment Research on MSNPfizer Stock Down Almost 11% YTD: Should You Buy the Dip?Pfizer’s PFE stock has declined 10.7% so far this year compared with a decrease of 7.7% for the industry. The stock has also ...
In anticipation of the next big one, the U.S. government began bolstering the nation’s pandemic flu defenses during the George W. Bush administration. These strategies were designed by the security ...
A new batch of Covid-19 vaccines is now available, says the Health Ministry. In a post on X, it said the vaccines are available at government health clinics. “For your information, the vaccines are ...
Its dividend: The stock recently yielded a whopping 7.3%. That's hard to beat and will generate around $730 for every $10,000 ...
The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...
But new research published in JAMA Pediatrics found distinct patterns of long COVID symptoms in young children. Researchers ...
A new COVID variant - NB 1.8.1 - is creeping across California; here are the symptoms to watch for, and vaccinations you'll ...
Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Lately, Pfizer (NYSE: PFE) ...
A new COVID variant - NB 1.8.1 - is creeping across the country; here are the symptoms to watch for, and vaccinations you'll need to take.
BMS will co-develop and co-commercialize BioNTech’s bispecific antibody BNT327 for solid tumors in a deal worth up to $11.1B ...
In the assessment of 12-month price targets, analysts unveil insights for BioNTech, presenting an average target of $138.7, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results